RT @drdavidliew: Rituximab/belimumab patients & COVID vaccination response: may have had average antibody response b
Tweet Content
Rituximab/belimumab patients & COVID vaccination response:
may have had average antibody response
but there’s still the cellular response to consider too! Not as bad.
Still caution++, but when ritux really needed we’ll find a way despite COVID
from roundup #EULAR2022 @RheumNow https://t.co/zFr6QI9TOG
Show on Archive Page
On
Display in Search Results
On
PDQ
Off